January 30, 2025
Lisbon, Portugal
Margarida Ochoa
MICK® participated in the 2nd Scientific Meeting of the Portuguese Society for Innovation in Microbiome and Probiotics (SPIMP)—a dynamic forum for discussing the latest advances in microbiome research and its practical applications in healthcare.
Held in Lisbon, the meeting gathered scientists, clinicians, and industry experts to share findings in areas like gut health, probiotic therapies, and next-generation product development. The program emphasized translational science and innovation, aligning closely with MICK®’s focus on bioinformatics tools for clinical microbiome interpretation.
This event also marked a valuable opportunity to strengthen collaborations and remain engaged with the microbiome innovation ecosystem in Southern Europe.
SEQUENTIA® BIOTECH SL
Barcelona
+34 930 107 368
* Sending the email implies acceptance of the Privacy Policy.
MICK® is co-founded by the European Union - grant agreement 190195702
European Union Funding H2020 Research and Innovation programme - grant agreement #868117
MICK® does not claim to diagnose, treat, cure, or prevent any disease. The information on the MICK® website is provided for informational purposes only and with the understanding that MICK® is not engaged in rendering medical advice or recommendations. You should not rely on any information on the website to diagnose or treat a health problem or condition or replace consultations with qualified health care professionals to meet your individual needs. Always check with your doctor for answers to your personal medical questions.
Copyright © Sequentia® Biotech 2024